Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility of Cardiac Neuromodulation Therapy (CNT) as Treatment for HFpEF

NCT07598760 is registered in ClinicalTrials.gov with BackBeat Medical Inc as lead sponsor.

NCT NCT07598760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07598760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility of Cardiac Neuromodulation Therapy (CNT) as Treatment for HFpEF
Lead sponsor
BackBeat Medical Inc
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 30, 2026
Completion date
November 30, 2028
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction (hfpef, hypertension (htn), hypertension, systolic